Indaptus Therapeutics, Inc. — Director's Dealing 2026

Feb 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2026-02-26

Reporting Person: Jabbour Jerome D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-26	Option to Buy Common Stock	$2.06	A	25000	Acquired	2036-02-26	Common Stock (25000)	Direct

Footnotes

F1: The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Issuer's board of directors through each vesting date.